Efficacy of rabeprazole-based triple therapy in treatment of helicobacter pylori positive patient with portal hypertension gastric disease
- VernacularTitle:雷贝拉唑在门脉高压性胃病中治疗幽门螺杆菌的疗效
- Author:
Xuanjie PENG
- Publication Type:Journal Article
- Keywords:
rabeprazole;
helicobacter pylori;
efficacy
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2004;0(12):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05 ). Few major severe adverse events were reported. The mild-moderate side effect rate in RFA group and OFA group were 28.1 % and 53.3 %, respectively (P 0.05 ), but RFA group is obviously lower than the OFA group in the side-effect of drugs, so it is an ideal therapy.
